In another study, GLP-1 and exendin-4 treatment was shown to normalize the altered vascular tone in type 2 diabetic rats, with the latter being less effective [115]
Meet our doctors Last reviewed: 02 Jun 2026 Sources A Research Study to See How Semaglutide Helps People With Excess Weight, Lose Weight (STEP UP) (STEP UP), Diabetes & endocrinology [accessed 26 September 2025] MHRA approves GLP1 receptor agonist semaglutide to reduce risk of serious heart problems in obese or overweight adults, GOV.UK [accessed 26 September 2025] Novo Nordisk submits higher Wegovy dose to the European Medicines Agency for approval, Reuters [accessed 26 September 2025] Once-weekly semaglutide 72 mg in adults with obesity (STEP UP): a randomised, controlled, phase 3b trial, The Lancet [accessed 26 September 2025] Wegovy 2.4 mg, FlexTouch solution for injection in pre-filled pen (PIL), emc [accessed 26 September 2025]
Effect of L-Arginine Supplementation on Blood Pressure in Adults: A Systematic Review and Dose-Response Meta-analysis of Randomized Clinical Trials
Understanding this natural rhythm helps you recognize normal medication behavior versus actual hunger returning, which supports better adherence to your treatment plan
